SS Innovations completes first telesurgery with new SSi Mantra console

SS Innovations International Inc. today said it has completed the first telesurgery with its SSi Mantra Tele Surgeon Console, or TSC. The company unveiled the system in 2024 and has since made a number of technological refinements.

The TSC is a compact, self-contained chair-based version of the larger SSi Mantra surgeon command center. SS Innovations said the design enables portability, requires less space, and facilitates the performance of telesurgeries from a wide range of settings, including physician offices.

“We believe that the SSi Mantra Tele Surgeon Console will offer significant advantages for telesurgery applications in the future and promote greater patient access to surgical expertise,” stated Dr. Sudhir Srivastava, chairman of the board and CEO of SS Innovation. “The TSC is a compact, self-contained chair with inbuilt electronics, supported by lightweight glasses and magnified three-dimensional view capabilities, as well as magnetic sensor-based controls.”

“The TSC has a smaller footprint compared to our standard surgeon command center, providing hospital networks with flexibility to place consoles in the offices of surgical experts without tying up entire operating rooms,” he added. “As long as connectivity is available, we believe that telesurgery and physician expertise can be extended from anywhere using the TSC.”

SS Innovations continues to advance telesurgery

Fort Lauderdale, Fla.-based SS Innovations said it has developed systems to make robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary SSi Mantra multi-arm system and its suite of SSi Mudra instruments.

SS Innovations has made progress in the past year in advancing its teleoperation capabilities. To date, 35 telesurgeries, including 10 cardiac procedures, and a total of 250 cardiac procedures have been completed with the SSi Mantra. Its first in the Americas took place in June.

In September, Dr. Chandra Mohan Vaddi, managing director of Preeti Urology & Kidney Hospitals, conducted a pediatric pyeloplasty (kidney surgery) from SS Innovations’ headquarters in Gurugram, India, nearly 1,000 mi. (1,609.3 km) away from a 16-month-old patient at Preeti Hospital in Hyderabad, India.

Last month, SS Innovations completed a human factors validation study for SSi Mantra for the U.S. Food and Drug Administration, with the goal of getting FDA approval in early 2026.

Dr. Chandra Mohan Vaddi performs remote surgery in India using SSi Mantra. Source: SS Innovations

SSi Mantra TSC demonstrates benefits of compact design

Last month, Srivastava used the TSC for the first time to remotely perform a robot-assisted coronary artery bypass procedure from his residence in New Delhi, India, on a patient about 185 miles away at Manipal Hospital in Jaipur, India.

SS Innovations said this milestone demonstrates the benefits of the TSC’s compact design, which enables the provision of surgical expertise from the office of any physician without requiring the resources of an entire operating room.

The company described SSi Mantra as a user-friendly, modular system with advanced technology features including:

Three to five modular robotic arms
An open-faced ergonomic surgeon command center
A large 3D 4K touch-panel monitor for all patient-related information display
A virtual real-time image of the robotic patient side arm carts
The ability for superimposition of 3D models of diagnostic imaging

A vision cart provides the table-side team with the same magnified view as the surgeon to provide better safety and efficiency. The SSi Mantra can work with more than 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, said the company.